The Ultimate Directory on Healthcare Webinars

Join this informative webinar to explore lupus solutions and real-world treatment impacts through a discussion on patient aspects and the role of technology in streamlining research efficiency. Lupus is a complex disease with diverse manifestations, limited treatment options and inequitable impact on the affected population. This makes research into patient experience, treatment patterns and long-term clinical outcomes particularly challenging. High-quality real-world data (RWD) can enable researchers to assess the current disease burden and generate evidence on the impact of new and established treatments in a highly efficient way, including exploring new hypotheses and capturing long-term outcomes. “Ideal” sources of RWD for Lupus would include the following components: - Demographic and socioeconomic data - Deep clinical information on disease manifestations - Health care utilization, including treatment information - Long-term clinical outcomes, including patient-reported outcomes (PROs) Join Alira Health’s Real World Solutions experts and external partners from FORWARD — the US national databank for rheumatic diseases — for a deep dive into Lupus RWD.

Sightsavers and the Royal Society of Tropical Medicine and Hygiene (RSTMH) are holding an online event on 23 January 2024 to share and discuss learnings around how to eliminate the infectious eye disease trachoma. The event, which will take place from 2PM – 4PM GMT, will share the findings from a new collection of research papers – 'Trachoma: Accelerating progress to elimination as a public health problem' in the RSTMH journal International Health. You can read the research supplement here. The event will focus on two topics: How governments and their partners can use innovative approaches to speed up the elimination of trachoma, and How to address advanced trachoma (known as ‘trichiasis’) in affected communities. Speakers will be sharing the latest insights from major trachoma initiatives such as the Accelerate and Tropical Data programmes, and attendees will have the opportunity to discuss these during a series of Q&A sessions. This collection of papers is the last to be published as part of a three-year partnership, in which RSTMH has used its scientific journals and other communications channels to help disseminate the key outputs and learnings from Sightsavers’ lead programmes.

We believe digital is now a wider determinant of health. As well as shaping access to health and care services, digital impacts across all aspects of our lives, affecting our opportunities and shaping health inequalities. Digital technologies and online services can improve health and wellbeing – as long as people have the access, skills, confidence and support to benefit. Join us for a three part seminar series, where you will hear from a range of VCSE Health and Wellbeing Alliance members, sharing learnings, case studies and examples of best practice for designing for digital inclusion in healthcare.

Cryopreservation, a cornerstone in the field of cell therapy, is the process of preserving biological source materials at ultra-low temperatures to maintain their viability and functionality for future therapeutic applications. In this webinar, industry experts will share their experience on the critical importance of cryopreservation, discussing considerations such as processing requirements, buffer composition, controlled rate freezing, and cold chain logistics. Join this webinar to learn about cryopreservation, a vital step in the manufacturing of today’s cell and gene therapies.

The challenge of running successful global trials is highly demanding and has become increasingly costly. Sourcing commercially available medications for these trials can be both complex and resource-intensive. This webinar will introduce innovative sourcing strategies for commercially available medications while assessing the pros and cons of the different options. The speaker will provide insight into key considerations when choosing the appropriate sourcing option(s) and discuss the value of migrating from a transactional approach to strategic sourcing.

Attend this webinar to learn more about Percutaneous leaflet repair and replacement, tricuspid regurgitation, Tricuspid TEER, also known as edge-to-edge repair, and percutaneous tricuspid valve replacement, the new treatment options for patients with severe tricuspid regurgitation. Join this webinar if you want to further understand the pathophysiology of TR, or need guidance on clinical and imaging selection of patients who might be suitable for treatment. This webinar is aimed at all clinicians involved in the management of patients with tricuspid regurgitation.

Sponsored by MGRI Division of Clinical Research and Harvard Center for Bioethics Title: Ethical Considerations of Access to Investigational Medicines Speaker: Karla G. Childers, BA, MSJ, MSBE, Head, Bioethics-based Science & Technology Policy, Office of the Chief Medical Officer, Johnson & Johnson

Sarcoma Foundation of America is dedicated to fostering the development of innovative treatment options for those affected by sarcoma. In collaboration with the esteemed CDRC Sarcoma Task Force, we are excited to present a pioneering project that delves into the potential of repurposing existing medications for the benefit of sarcoma patients. This initiative is at the forefront of leveraging real-world data—from electronic medical records to invaluable insights shared by patients and their healthcare providers. The goal is to illuminate the path to cost-effective treatments, harnessing the power of existing drugs that, while proven safe, require further evidence to support their novel application in sarcoma therapy. Your involvement is crucial in propelling this research forward, paving the way for new, accessible treatment avenues for the sarcoma community.

The evolving landscape of immune-oncology and cancer therapy research is being profoundly reshaped by single-cell RNA sequencing technologies. Join this webinar to discover the significance of single-cell omics profiling in oncological research, unraveling tumor microenvironment complexities post-immune therapies using single-cell RNA sequencing, and detailed analysis of transcriptional changes in specific cell types under various conditions.

Discover an informative webinar delving into DNA-encoded library (DEL) technology in drug discovery, showcasing tailored campaigns, parallel screening and innovative hit identification for challenging targets.